Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Evaluation of perinuclear antineutrophilic cytoplasmic antibodies in sera from dogs with inflammatory bowel disease or intestinal lymphoma.

Mancho C, Sainz Á, García-Sancho M, Villaescusa A, Rodríguez-Franco F.

Am J Vet Res. 2011 Oct;72(10):1333-7. doi: 10.2460/ajvr.72.10.1333.

PMID:
21962275
2.

Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease.

Allenspach K, Luckschander N, Styner M, Seibold F, Doherr M, Aeschbach D, Gaschen F.

Am J Vet Res. 2004 Sep;65(9):1279-83. Erratum in: Am J Vet Res. 2004 Dec;65(12):1707.

PMID:
15478778
3.

Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease.

Luckschander N, Allenspach K, Hall J, Seibold F, Gröne A, Doherr MG, Gaschen F.

J Vet Intern Med. 2006 Mar-Apr;20(2):221-7.

4.

Prevalence of perinuclear antineutrophilic cytoplasmic autoantibodies in serum of healthy Soft Coated Wheaten Terriers in the United Kingdom.

Wieland B, Summers JF, Häsler B, Mancho-Alonso C, Craig A, Allenspach K.

Am J Vet Res. 2012 Mar;73(3):404-8. doi: 10.2460/ajvr.73.3.404.

PMID:
22369533
5.

Perinuclear antineutrophil cytoplasmic autoantibodies in dogs infected with various vector-borne pathogens and in dogs with immune-mediated hemolytic anemia.

Karagianni AE, Solano-Gallego L, Breitschwerdt EB, Gaschen FP, Day MJ, Trotta M, Wieland B, Allenspach K.

Am J Vet Res. 2012 Sep;73(9):1403-9. doi: 10.2460/ajvr.73.9.1403.

PMID:
22924722
6.

Anti-alpha-enolase antibodies in patients with inflammatory Bowel disease.

Vermeulen N, Arijs I, Joossens S, Vermeire S, Clerens S, Van den Bergh K, Michiels G, Arckens L, Schuit F, Van Lommel L, Rutgeerts P, Bossuyt X.

Clin Chem. 2008 Mar;54(3):534-41. doi: 10.1373/clinchem.2007.098368. Epub 2008 Jan 24.

7.

Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.

Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P.

Am J Gastroenterol. 2001 Mar;96(3):730-4.

PMID:
11280542
8.

The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.

Zhou F, Xia B, Wang F, Shrestha UK, Chen M, Wang H, Shi X, Chen Z, Li J.

Clin Chim Acta. 2010 Oct 9;411(19-20):1461-5. doi: 10.1016/j.cca.2010.05.041. Epub 2010 Jun 4.

PMID:
20570669
9.

Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease.

Mancho C, Sainz A, García-Sancho M, Villaescusa A, Tesouro MA, Rodríguez-Franco F.

J Vet Diagn Invest. 2010 Jul;22(4):553-8.

PMID:
20622225
10.

Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: prevalence and diagnostic value.

Olives JP, Breton A, Hugot JP, Oksman F, Johannet C, Ghisolfi J, Navarro J, Cézard JP.

J Pediatr Gastroenterol Nutr. 1997 Aug;25(2):142-8.

PMID:
9252899
11.

Evaluation of lymphocyte apoptosis in dogs with inflammatory bowel disease.

Dandrieux JR, Bornand VF, Doherr MG, Kano R, Zurbriggen A, Burgener IA.

Am J Vet Res. 2008 Oct;69(10):1279-85. doi: 10.2460/ajvr.69.10.1279.

PMID:
18828683
12.

Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?

Seibold F, Weber P, Schöning A, Mörk H, Goppel S, Scheurlen M.

Eur J Gastroenterol Hepatol. 1996 Nov;8(11):1095-100.

PMID:
8944372
14.
15.

Changes in Foxp3-Positive Regulatory T Cell Number in the Intestine of Dogs With Idiopathic Inflammatory Bowel Disease and Intestinal Lymphoma.

Maeda S, Ohno K, Fujiwara-Igarashi A, Uchida K, Tsujimoto H.

Vet Pathol. 2016 Jan;53(1):102-12. doi: 10.1177/0300985815591081. Epub 2015 Jul 14.

PMID:
26173451
16.

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.

Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D.

Gut. 1998 Jun;42(6):788-91.

17.

Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.

Nisihara RM, de Carvalho WB, Utiyama SR, Amarante H, Baptista ML.

Dig Dis Sci. 2010 Aug;55(8):2309-15. doi: 10.1007/s10620-009-0998-7. Epub 2009 Oct 14.

PMID:
19826949
18.

Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value.

Homsak E, Micetić-Turk D, Bozic B.

Wien Klin Wochenschr. 2010 May;122 Suppl 2:19-25. doi: 10.1007/s00508-010-1344-y.

PMID:
20517666
19.

Atypical, cytoplasmic and perinuclear anti-neutrophil cytoplasmic antibodies in patients with inflammatory bowel disease.

Frenzer A, Fierz W, Rundler E, Hammer B, Binek J.

J Gastroenterol Hepatol. 1998 Sep;13(9):950-4.

PMID:
9794196
20.

Decreased immunoglobulin A concentrations in feces, duodenum, and peripheral blood mononuclear cells of dogs with inflammatory bowel disease.

Maeda S, Ohno K, Uchida K, Nakashima K, Fukushima K, Tsukamoto A, Nakajima M, Fujino Y, Tsujimoto H.

J Vet Intern Med. 2013 Jan-Feb;27(1):47-55. doi: 10.1111/jvim.12023. Epub 2012 Dec 6.

Supplemental Content

Support Center